Daxor Corporation (NASDAQ:DXR) Short Interest Down 42.2% in July

Daxor Corporation (NASDAQ:DXR - Get Free Report) saw a large drop in short interest in July. As of July 31st, there was short interest totaling 6,300 shares, adropof42.2% from the July 15th total of 10,900 shares. Based on an average daily trading volume, of 26,400 shares, the short-interest ratio is currently 0.2 days. Approximately0.3% of the company's stock are sold short. Approximately0.3% of the company's stock are sold short. Based on an average daily trading volume, of 26,400 shares, the short-interest ratio is currently 0.2 days. Daxor Trading Down 0.1%Shares of DXR opened at $10.60 on Monday. The business's fifty day simple moving average is $9.63 and its two-hundred day simple moving average is $8.41. Daxor has a 12 month low of $6.55 and a 12 month high of $11.38.Hedge Funds Weigh In On DaxorAn institutional investor recently raised its position in Daxor stock. Renaissance Technologies LLC raised its holdings in shares of Daxor Corporation (NASDAQ:DXR - Free Report) by 87.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,821 shares of the company's stock after acquiring an additional 13,000 shares during the quarter. Renaissance Technologies LLC owned approximately 0.57% of Daxor worth $214,000 as of its most recent SEC filing. 1.34% of the stock is currently owned by institutional investors. Daxor Company Profile (Get Free Report)Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.Read MoreFive stocks we like better than DaxorInvesting In Automotive StocksTravel Stocks Rally on Earnings—More Upside Ahead?Natural Gas Prices Continue To Rally, These Stocks Should BenefitSilver Prices Up, But Endeavour’s Profit Still Elusive3 Stocks to Consider Buying in OctoberCocoa Futures Send Hershey Stock Lower, Dip Opportunity?This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Daxor Right Now?Before you consider Daxor, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Daxor wasn't on the list.While Daxor currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here